Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 YEARS CONSIDERED FOR THE STUDY
2.3 CURRENCY AND PRICING
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELLING
2.6 PRODUCT TYPE LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 INDUSTRIAL INSIGHTS:
5 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CANCER AND NEUROLOGICAL DISORDER
6.1.2 INCREASE IN GERIATRIC POPULATION
6.1.3 INCREASE IN EARLY DIAGNOSIS RATE
6.1.4 INCREASE IN ADVANCED TECHNOLOGY
6.2 RESTRAINTS
6.2.1 HIGH COST OF PRODUCTS
6.2.2 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS
6.2.3 PRESENCE OF ALTERNATIVE TECHNIQUES
6.3 OPPORTUNITIES
6.3.1 RISE IN GOVERNMENT FUNDING FOR HEALTHCARE
6.3.2 RISE IN HEALTHCARE EXPENDITURE
6.4 CHALLENGES
6.4.1 LACK OF SKILLED WORKFORCE
6.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS
7 IMPACT OF COVID-19 PANDEMIC ON THE MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
7.5 CONCLUSION
8 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 KITS AND REAGENTS
8.3 INSTRUMENTS
8.4 CONSUMABLES
9 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY SERVICES
9.1 OVERVIEW
9.2 SAMPLE COLLECTION
9.2.1 PLASMA
9.2.2 SERUM
9.2.3 WHOLE BLOOD
9.2.4 OTHERS
9.3 OTHER SERVICES
10 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD
10.1 BY METHOD TYPES
10.1.1 OVERVIEW
10.1.2 REVERSE TRANSCRIPTION
10.1.3 QPCR
10.2 ON THE BASIS OF RT-QPCR
10.2.1 OVERVIEW
10.2.2 STEM LOOP RT-QPCR
10.2.3 POLYADENYLATION BASED RT-QPCR
10.2.4 MI-QPCR
10.2.5 OTHERS
10.3 ON THE BASIS OF KITS, REAGENTS AND CONSUMABLES
10.3.1 OVERVIEW
10.3.2 QUANTITATIVE PCR
10.3.3 RNA-SEQUENCING
10.3.4 MICROARRAYS
10.3.5 IN-SITU HYBRIDIZATION
10.3.6 OTHERS
11 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 CANCER
11.3 CARDIOVASCULAR DISEASE
11.4 NEUROLOGICAL DISEASE
11.5 KIDNEY DISEASE
11.6 OTHERS
12 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY END USER
12.1 OVERVIEW
12.2 ACADEMIC AND RESEARCH INSTITUTES
12.3 BIOPHARMACEUTICAL COMPANIES
12.4 CONTRACT RESEARCH ORGANIZATIONS
12.5 DIAGNOSTIC CENTERS
13 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
14 COMPANY PROFILE
14.1 THERMO FISHER SCIENTIFIC INC
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 ILLUMINA, INC
14.2.1 COMPANY SNAPSHOT
14.2.2 RECENT FINANCIALS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 AGILENT TECHNOLOGIES, INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENTS
14.4 BIO-RAD LABORATORIES, INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 MERCK KGAA, DARMSTADT, GERMANY
14.5.1 COMPANY SNAPSHOT
14.5.2 RECENT FINANCIALS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENTS
14.6 QIAGEN
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 ABCAM PLC
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 APPLIED BIOLOGICAL MATERIALS INC. (ABM)
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 BIOGENEX
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 GENECOPOEIA, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 GENOSENSOR CORPORATION
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 HTG MOLECULAR DIAGNOSTICS, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 RECENT FINANCIALS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 HORIZON DISCOVERY LTD.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.14 MILTENYI BIOTEC
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 MIRXES PTE LTD
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 NANJING VAZYME BIOTECH CO.,LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 NANOSTRING
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENT
14.18 NEW ENGLAND BIOLABS
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENTS
14.19 NORGEN BIOTEK CORP.
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 ORIGENE TECHNOLOGIES, INC.
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 QUANTABIO
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENTS
14.22 SEQMATIC LLC.
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENT
14.23 SYSTEM BIOSCIENCES, LLC.
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENT
14.24 TAKARA BIO INC.
14.24.1 COMPANY SNAPSHOT
14.24.2 RECENT FINANCIALS
14.24.3 PRODUCT PORTFOLIO
14.24.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 2 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 3 GLOBAL SAMPLE COLLECTION IN MICRORNA REVERSE TRANSCRIPTION MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 4 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 5 GLOBAL RT-QPCR IN MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 6 GLOBAL KITS, REAGENTS AND CONSUMABLES IN MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 7 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 8 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY END USER, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: SEGMENTATION
FIGURE 2 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: GLOBAL VS REGIONAL ANALYSIS
FIGURE 5 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF CANCER AND NEUROLOGICAL DISORDER IS EXPECTED TO DRIVE THE GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET
FIGURE 14 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY PRODUCT TYPE, 2021
FIGURE 15 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 16 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 17 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY SERVICES, 2021
FIGURE 19 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY SERVICES, 2022-2029 (USD MILLION)
FIGURE 20 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY SERVICES, CAGR (2022-2029)
FIGURE 21 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY SERVICES, LIFELINE CURVE
FIGURE 22 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, 2021
FIGURE 23 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2022-2029 (USD MILLION)
FIGURE 24 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, CAGR (2022-2029)
FIGURE 25 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, LIFELINE CURVE
FIGURE 26 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, 2021
FIGURE 27 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2022-2029 (USD MILLION)
FIGURE 28 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, CAGR (2022-2029)
FIGURE 29 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, LIFELINE CURVE
FIGURE 30 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, 2021
FIGURE 31 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2022-2029 (USD MILLION)
FIGURE 32 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, CAGR (2022-2029)
FIGURE 33 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, LIFELINE CURVE
FIGURE 34 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY APPLICATION, 2021
FIGURE 35 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 36 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 37 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 38 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY END USER, 2021
FIGURE 39 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY END USER, 2022-2029 (USD MILLION)
FIGURE 40 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY END USER, CAGR (2022-2029)
FIGURE 41 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: COMPANY SHARE 2021 (%)